Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies

• Main Authors: R. L. Bromley (Author), M. Bickle Graz (Author), M. Bluett-Duncan (Author), C. Chambers (Author), P. Damkier (Author), K. Dietrich (Author), H. Dolk (Author), K. Grant (Author), S. Mattson (Author), K. J. Meador (Author), H. Nordeng (Author), T. F. Oberlander (Author), A. Ornoy (Author), A. Revet (Author), J. Richardson (Author), J. Rovet (Author), L. Schuler-Faccini (Author), E. Smearman (Author), V. Simms (Author), C. Vorhees (Author), K. Wide (Author), A. Wood (Author), L. Yates (Author), E. Ystrom (Author), T. A. Supraja (Author), J. Adams (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Exposure in utero to certain medications can disrupt processes of fetal development, including brain development, leading to a continuum of neurodevelopmental difficulties. Recognizing the deficiency of neurodevelopmental investigations within pregnancy pharmacovigilance, an internationa...